P. Wehmeier

发表

Body image assessment using body size estimation in recent studies on anorexia nervosa. A brief review.

H. Remschmidt, S. Skrzypek, P. Wehmeier, 2001, European Child & Adolescent Psychiatry.

Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life.

R. Barkley, P. Wehmeier, A. Schacht, 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

T. Pollmächer, R. Dittmann, T. Kraus, 2009, Psychoneuroendocrinology.

A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-being.

D. Naber, R. Dittmann, S. Beyenburg, 2005, Pharmacopsychiatry.

Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs

J. Hebebrand, H. Remschmidt, J. Schmidtke, 2005, Psychiatric genetics.

Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation

J. Hebebrand, H. Remschmidt, J. Schmidtke, 2005, Psychiatry Research.

Findings from the observational COMPLY study in children and adolescents with ADHD: core symptoms, ADHD-related difficulties, and patients’ emotional expression during psychostimulant or nonstimulant ADHD treatment

T. Banaschewski, R. Dittmann, P. Wehmeier, 2014, ADHD Attention Deficit and Hyperactivity Disorders.

Serum leptin levels and resting energy expenditure during weight gain in a patient with anorexia nervosa: a case study

J. Hebebrand, H. Remschmidt, W. Blum, 1999 .

Long-term patterns of subjective wellbeing in schizophrenia: Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years

M. Lambert, D. Naber, R. Dittmann, 2008, Schizophrenia Research.

[Psychiatric illness from a multi-generational perspective: results of a longitudinal study with children and grandchildren of hospitalized depressed patients].

H. Remschmidt, U. König, P. Wehmeier, 2001, Praxis der Kinderpsychologie und Kinderpsychiatrie.

Psychotherapy with children and adolescents

H. Remschmidt, P. Wehmeier, H. Crimlisk, 2001 .

Induced Delusional Disorder

H. Remschmidt, P. Wehmeier, N. Barth, 2003, Psychopathology.

Development and Validation of a Brief Measure of Self-Management Competence: The Self-Management Self-Test (SMST)

U. Nater, P. Wehmeier, Johanna M. Doerr, 2020, Therapeutic Innovation & Regulatory Science.

Development and Validation of a Brief Measure of Self-Management Competence: The Self-Management Self-Test (SMST)

U. Nater, P. Wehmeier, Johanna M. Doerr, 2019, Therapeutic innovation & regulatory science.

Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder and Oppositional Defiant Disorder

Rodney J. Moore, P. Hoare, D. Coghill, 2008, Pediatrics.

Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine

H. Remschmidt, P. Wehmeier, P. Heiser, 2005, Journal of clinical pharmacy and therapeutics.

Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature

T. Pollmächer, R. Dittmann, T. Kraus, 2014, Schizophrenia Research.

Weight criteria for diagnosis of anorexia nervosa.

J. Hebebrand, H. Remschmidt, P. Wehmeier, 2000, American Journal of Psychiatry.

Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials

P. Wehmeier, A. Schacht, T. Wagner, 2011, Attention deficit and hyperactivity disorders.

Quality of Life and Attention-Deficit/Hyperactivity Disorder Core Symptoms: A Pooled Analysis of 5 Non-US Atomoxetine Clinical Trials

P. Wehmeier, A. Schacht, T. Wagner, 2010, Journal of clinical psychopharmacology.

Olanzapine in male and female adolescent patients with schizophrenia and related disorders: minor sex differences in outcomes.

Martin H. Schmidt, F. Poustka, H. Remschmidt, 2010, Journal of clinical psychopharmacology.

Effectiveness and tolerability of olanzapine in the treatment of adolescents with schizophrenia and related psychotic disorders: results from a large, prospective, open-label study.

Martin H. Schmidt, F. Poustka, H. Remschmidt, 2008, Journal of child and adolescent psychopharmacology.

Clozapine and Olanzapine Are Associated With Food Craving and Binge Eating: Results From A Randomized Double-Blind Study

T. Pollmächer, R. Dittmann, T. Kraus, 2007, Journal of clinical psychopharmacology.

Patterns of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.

M. Lambert, P. Wehmeier, B. Schimmelmann, 2008, Journal of psychiatric research.

Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia

P. Wehmeier, A. Schacht, M. Kluge, 2007, Schizophrenia Research.

Effect of atomoxetine on quality of life and family burden: results from a randomized, placebo-controlled, double-blind study in children and adolescents with ADHD and comorbid oppositional defiant or conduct disorder

M. Bullinger, R. Dittmann, P. Wehmeier, 2011, Quality of Life Research.

Chart review for potential features of myocarditis, pericarditis, and cardiomyopathy in children and adolescents treated with clozapine.

H. Remschmidt, P. Wehmeier, P. Heiser, 2004, Journal of child and adolescent psychopharmacology.

Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)

R. Dittmann, J. March, P. Wehmeier, 2008 .

Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.

G. Lehmkuhl, R. Dittmann, P. Wehmeier, 2011, Journal of child and adolescent psychopharmacology.

A. Hervás, P. Wehmeier, A. Schacht, 2012, ADHD Attention Deficit and Hyperactivity Disorders.

Differences between children and adolescents in treatment response to atomoxetine and the correlation between health-related quality of life and Attention Deficit/Hyperactivity Disorder core symptoms: Meta-analysis of five atomoxetine trials

V. Harpin, P. Wehmeier, A. Schacht, 2010, Child and adolescent psychiatry and mental health.

Does Comorbid Disruptive Behavior Modify the Effects of Atomoxetine on ADHD Symptoms as Measured by a Continuous Performance Test and a Motion Tracking Device?

T. Banaschewski, R. Dittmann, P. Wehmeier, 2015, Journal of attention disorders.

Does Stimulant Pretreatment Modify Atomoxetine Effects on Core Symptoms of ADHD in Children Assessed by Quantitative Measurement Technology?

T. Banaschewski, R. Dittmann, P. Wehmeier, 2014, Journal of attention disorders.

Induced delusional disorder. a review of the concept and an unusual case of folie à famille.

H. Remschmidt, P. Wehmeier, N. Barth, 2003, Psychopathology.

Minor differences in ADHD-related difficulties between boys and girls treated with atomoxetine for attention-deficit/hyperactivity disorder

T. Banaschewski, R. Dittmann, P. Wehmeier, 2010, Attention deficit and hyperactivity disorders.

Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attention-deficit/hyperactivity disorder (ADHD): findings from two 24-week, open-label studies.

G. Lehmkuhl, R. Dittmann, P. Wehmeier, 2009, Child and adolescent psychiatry and mental health.

Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate

J. Hebebrand, H. Remschmidt, P. Wehmeier, 2004, European Child & Adolescent Psychiatry.

Evaluation of Patient- and Parent-Rated Emotional Expression Using theExpression and Emotion Scale for Children (EESC) in an ObservationalStudy of ADHD in Children and Adolescents

P. Wehmeier, M. Huss, A. Schacht, 2012 .

Self-esteem in adolescent patients with attention-deficit/hyperactivity disorder during open-label atomoxetine treatment: psychometric evaluation of the Rosenberg Self-Esteem Scale and clinical findings

G. Lehmkuhl, R. Dittmann, P. Wehmeier, 2009, Attention deficit and hyperactivity disorders.

Differential 3-Year Effects of First- Versus Second-Generation Antipsychotics on Subjective Well-Being in Schizophrenia Using Marginal Structural Models

J. Haro, M. Lambert, D. Naber, 2011, Journal of clinical psychopharmacology.

Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years

A. Rothenberger, P. Wehmeier, A. Schacht, 2009 .

Atomoxetine treatment and ADHD-related difficulties as assessed by adolescent patients, their parents and physicians

G. Lehmkuhl, R. Dittmann, P. Wehmeier, 2009, Child and Adolescent Psychiatry and Mental Health.

Effectiveness of atomoxetine and quality of life in children with attention-deficit/hyperactivity disorder as perceived by patients, parents, and physicians in an open-label study.

G. Lehmkuhl, R. Dittmann, P. Wehmeier, 2007, Journal of child and adolescent psychopharmacology.

Does Atomoxetine Improve Executive Function, Inhibitory Control, and Hyperactivity?: Results From a Placebo-Controlled Trial Using Quantitative Measurement Technology

T. Banaschewski, G. Lehmkuhl, R. Dittmann, 2012, Journal of clinical psychopharmacology.

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia

P. Wehmeier, A. Schacht, T. Wagner, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Sleep propensity at daytime as assessed by Multiple Sleep Latency Tests (MSLT) in patients with schizophrenia increases with clozapine and olanzapine

T. Pollmächer, R. Dittmann, T. Kraus, 2012, Schizophrenia Research.

Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study

J. Hebebrand, H. Remschmidt, S. Gebhardt, 2010, Journal of clinical pharmacy and therapeutics.

Neuropsychological outcomes across the day in children with attention-deficit/hyperactivity disorder treated with atomoxetine: results from a placebo-controlled study using a computer-based continuous performance test combined with an infra-red motion-tracking device.

T. Banaschewski, R. Dittmann, P. Wehmeier, 2011, Journal of child and adolescent psychopharmacology.

Global impression of perceived difficulties in children and adolescents with attention-deficit/hyperactivity disorder: Reliability and validity of a new instrument assessing perceived difficulties from a patient, parent and physician perspective over the day

Alexander Schacht, R. Dittmann, P. Wehmeier, 2008, Child and adolescent psychiatry and mental health.

Depressive syndromes and suicide

B. Herpertz-Dahlmann, H. Remschmidt, P. Wehmeier, 2001 .

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.

Rodney J. Moore, P. Hoare, D. Coghill, 2008 .

Child and Adolescent Psychiatry and Mental Health Change in the Direct Cost of Treatment for Children and Adolescents with Hyperkinetic Disorder in Germany over a Period of Four Years

A. Rothenberger, P. Wehmeier, A. Schacht, 2022 .

The effects of music therapy on the interaction of the self and emotions-An interim analysis.

R. von Georgi, S. Gebhardt, P. Wehmeier, 2018, Complementary therapies in medicine.

Treatment compliance or medication adherence in children and adolescents on ADHD medication in clinical practice: results from the COMPLY observational study

T. Banaschewski, R. Dittmann, P. Wehmeier, 2015, ADHD Attention Deficit and Hyperactivity Disorders.

Body weight gain induced by atypical antipsychotics: an extension of the monocygotic twin and sib pair study

P. Wehmeier, M. Haberhausen, F. Theisen, 2010, Journal of clinical pharmacy and therapeutics.

Muscular Complaints and Headache are Common Painful Physical Symptoms in Patients With Depression

R. Dittmann, M. Linden, P. Wehmeier, 2006 .

T. Banaschewski, R. Dittmann, P. Wehmeier, 2011, Journal of child and adolescent psychopharmacology.

Child and Adolescent Psychiatry and Mental Health Morning and Evening Behavior in Children and Adolescents Treated with Atomoxetine Once Daily for Attention-deficit/hyperactivity Disorder (adhd): Findings from Two 24-week, Open-label Studies

G. Lehmkuhl, R. Dittmann, P. Wehmeier, 2022 .